Andrei Barbulescu
Overview
Explore the profile of Andrei Barbulescu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barbulescu A, Sjolander A, Delcoigne B, Askling J, Frisell T
Rheumatology (Oxford)
. 2023 Feb;
62(10):3391-3399.
PMID: 36821426
Objective: Observational studies have reported an increased risk of infections associated with glucocorticoids in RA, not supported by evidence from randomized controlled trials. Inappropriately accommodating time-varying exposure and confounding in...
2.
Barbulescu A, Askling J, Saevarsdottir S, Kim S, Frisell T
Clin Pharmacol Ther
. 2022 Jun;
112(4):836-845.
PMID: 35652244
Observational studies are often considered unreliable for evaluating relative treatment effectiveness, but it has been suggested that following target trial protocols could reduce bias. Using observational data from patients with...
3.
Barbulescu A, Askling J, Chatzidionysiou K, Forsblad-dElia H, Kastbom A, Lindstrom U, et al.
Rheumatology (Oxford)
. 2022 Feb;
61(10):3952-3962.
PMID: 35134119
Objectives: To describe the use of baricitinib and tofacitinib by Swedish RA patients and to compare their effectiveness with that of biologic DMARDs (bDMARDs). Methods: RA patients who initiated baricitinib...
4.
Barbulescu A, Delcoigne B, Askling J, Frisell T
RMD Open
. 2020 Jul;
6(2).
PMID: 32669452
Objectives: To compare incidence rates of gastrointestinal (GI) perforations between patients with RA and the general population, and between patients treated with tumour necrosis factor inhibitors (TNFi) and non-TNFi biologics....
5.
Barbulescu A, Oskarsson V, Lindblad M, Ljung R, Brooke H
Clin Epidemiol
. 2018 Nov;
10:1573-1581.
PMID: 30464637
Objective: Oral metronidazole used in combined regimens for eradication has been associated with an increased risk of acute pancreatitis; however, it is less clear whether a similar association exists for...